Burning Rock Biotech Q2 EPS $(0.18) Up From $(0.37) YoY, Sales $20.17M Up From $19.53M YoY
Portfolio Pulse from Benzinga Newsdesk
Burning Rock Biotech (NASDAQ:BNR) reported Q2 losses of $(0.18) per share, a 51.35% increase YoY. The company also reported $20.17M in sales, a 3.27% increase YoY.
August 31, 2023 | 7:12 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Burning Rock Biotech reported improved Q2 earnings with reduced losses and increased sales YoY.
The reported earnings show a positive trend for Burning Rock Biotech with reduced losses and increased sales compared to the same period last year. This could potentially lead to a positive impact on the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100